These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28273554)

  • 21. The finding and evaluation of EMG-guided BOTOX injection in cervical dystonia.
    Lee LH; Chang WN; Chang CS
    Acta Neurol Taiwan; 2004 Jun; 13(2):71-6. PubMed ID: 15478678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ptosis as a remote effect of therapeutic botulinum toxin B injection.
    Racette BA; Lopate G; Good L; Sagitto S; Perlmutter JS
    Neurology; 2002 Nov; 59(9):1445-7. PubMed ID: 12427903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children.
    Boerner RM; Young DL; Gnagi SH; White DR; Halstead LA
    J Pediatr; 2018 Mar; 194():241-243. PubMed ID: 29275924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.
    Jiang H; Xiang Y; Hu X; Cai H
    Neural Regen Res; 2014 Aug; 9(16):1525-31. PubMed ID: 25317170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin: a new differential diagnosis for a lytic bone lesion.
    Lefkovits Y; Lipton L
    J Med Case Rep; 2024 Mar; 18(1):179. PubMed ID: 38521935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysarthria Associated with Lumbar Sympathetic Block Using Botulinum Toxin.
    Carcamo CR
    Pain Med; 2019 Aug; 20(8):1634-1635. PubMed ID: 30753626
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
    Langdon K; Blair E; Davidson SA; Valentine J
    Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
    [No Abstract]   [Full Text] [Related]  

  • 29. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria.
    Watts J; Brew B; Tisch S
    J Clin Neurosci; 2015 Dec; 22(12):1979-81. PubMed ID: 26188667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome.
    Nahab FB; Peckham EL; Hallett M
    Neurology; 2008 Sep; 71(12):950-1. PubMed ID: 18794499
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of previous botulinum neurotoxin treatment on microvascular decompression for hemifacial spasm.
    Wang X; Thirumala PD; Shah A; Gardner P; Habeych M; Crammond DJ; Balzer J; Horowitz M
    Neurosurg Focus; 2013 Mar; 34(3):E3. PubMed ID: 23452316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids.
    Matarasso SL; Matarasso A
    Plast Reconstr Surg; 2001 Jul; 108(1):208-14; discussion 215-7. PubMed ID: 11420526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans.
    Lispi L; Leonardi L; Petrucci A
    Neurol Sci; 2018 Feb; 39(2):329-332. PubMed ID: 29128986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
    Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
    Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iatrogenic botulism in a child with spastic quadriparesis.
    Partikian A; Mitchell WG
    J Child Neurol; 2007 Oct; 22(10):1235-7. PubMed ID: 17940253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis.
    Dadgardoust PD; Rosales RL; Asuncion RM; Dressler D
    J Neural Transm (Vienna); 2019 Feb; 126(2):141-148. PubMed ID: 30604200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jitter Evaluation in Distant and Adjacent Muscles after Botulinum Neurotoxin Type A Injection in 78 Cases.
    Kouyoumdjian JA; Graça CR; Oliveira FN
    Toxins (Basel); 2020 Aug; 12(9):. PubMed ID: 32867187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.